O. E. Knysh

O. E. Knysh

Auto-generated profile, based on publicly available information

O. E. Knysh

Ural State Medical University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Ural Medical Academic Science
Verified
Journal Article
Closed access
IMIrina Юрьевна Irina Yu. Maklakova
Irina Юрьевна Irina Yu. Maklakova
OKO.E. Knysh
O.E. Knysh
KGK.A. Gavrilova
K.A. Gavrilova
DED.S. Erlish
D.S. Erlish
DGDmitry Grebnev
Dmitry Grebnev
EUE.D. Uskov
E.D. Uskov
Introduction. Melanoma ranks fifth in terms of prevalence among all types of STDs in the world, demonstrating a rapid increase in the incidence rate over the past 10 years. The trend towards an increase in the prevalence of this MND, its growing resistance to existing therapies and, as a consequence, an increase in melanoma mortality indicates the need to consider new therapeutic approaches, one of which is the use of low-frequency electromagnetic fields (LF-EMF). The ability of EMF to inhibit melanoma cell population growth has been previously demonstrated, but this work is the first to investigate the effect of EMF on a melanoma cell line using an extremely low frequency — 5 Hz. The aim of the study is to identify the effect of EMF 5 Hz on the functional state of the melanoma cell line B16-F10. Materials and methods. The state of the B16-F10 melanoma cell line was analyzed after EMF irradiation (frequency 5 Hz, current force 5 A — 20 A — 30 A, single-bipolar field) for 1, 2, 3 hours. A review of the current scientific literature on the described topic. Results. In the mode of operation of the EMF 2 generator at exposition of 2 hours – increase of necrotic cells by 100% (p<0,001). In mode 3, exposure for 3 hours – increase in cells in a state of apoptosis by 24% with a pronounced dose dependence (p<0.05). Discussion. This study has confirmed that exposure to EMF-LF (5 Hz) is a promising approach in melanoma. Presumably, the observed effect (induction of oncocell death) is realized due to a change in intracellular Ca²⁺ homeostasis, which requires further research.

1 January 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
EKE. V. Kudryavtseva
E. V. Kudryavtseva
OKO. E. Knysh
O. E. Knysh
VPVladislav Petkau
Vladislav Petkau
EBE. R. Bikbulatova
E. R. Bikbulatova
IUI. G. Usynin
I. G. Usynin
Introduction . 5–10% of breast cancer (BC) cases are associated with germline pathogenic variants (PVs) in predisposition genes. In Russia, detection of “8 frequent” BRCA1,2 variants by PCR is recommended, with next generation sequensing (NGS) performed only at a second stage. Most studies on BC PVs have focused on BRCA1,2 , not exploring other candidate genes. Aim . Analyze the frequency and spectrum of PVs in candidate genes in patients with BC and healthy women with a family history of cancer. Materials and methods . Results of NGS testing (26-gene panel) on peripheral blood from 291 women were retrospectively analyzed. Participants were divided into 2 groups: 1 – patients with a history of BC (n = 146); 2 – women with 1 st /2 nd degree relatives diagnosed with BC or ovarian cancer (n = 145). Results . PVs were 2.5 times more frequent in Group 1 (21.2%) vs Group 2 (8.3%), р = 0,0012. BC onset with PVs occurred earlier than in women in whom significant genetic variants were not identified (39.3 ± 1 vs 44 ± 0,9 years, р = 0,01). PV in the BRCA1,2 genes were detected in 14.3% of group 1 and 6.2% of group 2, respectively. The most frequently detected variants were. BRCA1,2 PVs were most frequent (14.3% Grp1, 6.2% Grp2); Most common PVs were in BRCA1 : c.5266dupC, c.4035delA. BRCA1,2 PVs comprised only 68,18% of all PVs, confirming importance of testing other genes. CHEK2 PVs were frequent in Group 1 (4.8%), 7 times higher than Group 2 (р = 0,0076). CHEK2 :c.1100delC comprised 57% of these. 20.4% were VUS (variants of uncertain significance), often in non- BRCA genes. PVs in Group 2 were 8 times higher than general population rates. Conclusion . NGS enables detection of a full spectrum of clinically significant variants, requiring high expertise for interpretation.

20 October 2026 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
VPVladislav Petkau
Vladislav Petkau
ПВПеткау В. В.
Петкау В. В.
OKOleg E. Knysh
Oleg E. Knysh
КЕКныш Олег Евгеньевич
Кныш Олег Евгеньевич
ADA. V. Dorofeev
A. V. Dorofeev
МИМагдалянова М. И.
Магдалянова М. И.
Background. Lobular breast cancer (LBC) is a distinct histological subtype of breast cancer, whose incidence has significantly increased. However, breast cancer remains understudied compared to ductal breast cancer (DBC), evidenced by the lack of specific LBC-driven clinical guidelines. Aim. To establish the independence of LBC as a special form by showing its epidemiological, clinical, morphological, prognostic differences from DBC. Materials and methods. The first stage was an assessment of the incidence of DBC based on data from the Sverdlovsk region cancer registry in 2024; the second stage was an analysis of the clinical, morphological and prognostic features of DBC (n = 148) in comparison with LBC (n = 298). Results. The proportion of LBC in the overall breast cancer structure in the Sverdlovsk region in 2024 was 2.5 %. We observed a bimodal age distribution for LBC (peaks at 40–49 and 60–69 years), with a peak of 60–69 years in LBC. LBC had several features: frequent bilateral lesion, predominance of early stages and luminal subtypes, low-grade malignancy and unique microenvironment. Neoadjuvant therapy was less ineffective in LBC (pathomorphological complete response rate: 13,6 % vs. 36,4 %), primarily associated with the luminal subtypes predominance. However, aggressive LBC subtypes exhibited neoadjuvant therapy sensitivity comparable to DBC, underscoring the importance of molecular subtyping, even within distinct histology. A high frequency of positive breast cancer resection margins was associated with breast-conserving surgery, but repeat surgery to achieve negative margins significantly reduces the risk of recurrence. LBC metastases frequently involved the liver, bones, and lymph nodes; metastasis to serous membranes and ovaries was characteristic of LBC; whereas involvement of the lungs, skin and brain occurred less frequently than in DBC. Patients with LBC demonstrated superior survival compared to invasive DBC during early follow-up: 3-year disease-free survival for stage III was 78.7 % vs. 51.2 %, and 1-year overall survival for stage IV was 100 % vs. 38.9 %. Conclusion. LBC is a special form of breast cancer that has a number of features and requires more attention, research and the development of specific recommendations.

11 May 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Closed access
OPO. V. Prokhorova
O. V. Prokhorova
OKO. E. Knysh
O. E. Knysh
MKM. P. Kazachenkova
M. P. Kazachenkova
VZV. K. Zaitseva
V. K. Zaitseva
EKE. V. Knysh
E. V. Knysh
IGI. G. Goryachok
I. G. Goryachok
Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathy (TMA) driven by dysregulation of the alternative complement pathway. Within obstetrics, its diagnosis is critically confounded by profound clinical mimicry of common obstetrical emergencies. Delayed diagnosis is invariably associated with the rapid progression of multi-organ dysfunction syndrome (MODS), culminating in unacceptably high maternal and perinatal mortality and irreversible disability. This article presents a rare clinical case of aHUS triggered by placental abruption at 27 weeks of gestation in a patient with a history of two uncomplicated term deliveries. The initial clinical presentation was dominated by hemorrhagic shock and disseminated intravascular coagulation (DIC) secondary to massive abruption, which effectively masked the classic TMA triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. A systematic diagnostic workup including thromboelastography, schistocyte quantification, ADAMTS-13 activity assay, and renal biopsy was required to sequentially exclude other TMA subtypes and definitively establish the diagnosis. Despite a significant delay in initiating targeted therapy with the C5 complement inhibitor eculizumab and the development of severe acute kidney injury with cortical necrosis requiring prolonged renal replacement therapy (RRT), a favorable outcome was achieved. Eculizumab therapy facilitated gradual recovery of native renal function, culminating in the complete discontinuation of RRT. This case underscores placental abruption as a independent trigger for aHUS. It provides a compelling rationale for the inclusion of aHUS in the differential diagnosis of any complex obstetrical catastrophe and offers crucial clinical evidence supporting the potential for renal recovery following delayed initiation of complement blockade, even in the setting of severe, established parenchymal injury.

1 January 2025 in Journal of Ural Medical Academic Science
Verified
Journal Article
Closed access
KGK.A. Gavrilova
K.A. Gavrilova
TVT.A. Vaulina
T.A. Vaulina
EVE.A. Vakker
E.A. Vakker
EKE.S. Kolmakova
E.S. Kolmakova
OKO.E. Knysh
O.E. Knysh
DED.S. Erlish
D.S. Erlish
Introduction. From 2000 to 2019, the average life expectancy increased by 6.5 years worldwide, which led to an increase in the number of diseases characteristic of old age. The search for a geroprotector capable of both increasing life expectancy and improving its quality, preventing the development of age-related diseases, is relevant. The aim of the study was to study the geroprotective properties of fucoxanthin. Materials and methods. A single-center fundamental study was conducted on 60 outbred male ICR/CD1 mice aged 20 months. 60 mice were divided into 2 groups: 1st – 30 mice that did not receive fucoxanthin, 2nd – 30 mice that received orally the drug Fucoxanthin dissolved in water (TargetMol, USA) daily for 8 months. Changes in the general biochemical parameters of blood serum were recorded using the ChemWell 2910 biochemical analyzer from Awarenesstechnology and Spinreact reagents. The total AOA of serum was determined using a Sinnowabs 3000m biochemical analyzer and Vector Best reagents. The reagent “tetramethylbenzidine (TMB) + H₂O₂” for enzyme immunoassay by Diagnostic Systems LLC is used to determine total peroxidase activity. Total AOA of liver homogenate – using the Elabscience kit E-BC-K225-M. The content of malonic dialdehyde (MDA) in liver homogenate was determined using the Elabscience kit E-BC-K025-M. The optical density during the determination of AOA and MDA in the homogenate was recorded on a Multiscan Go ThermoFisher spectrophotometer. Statistical data processing was carried out in Jamovi. The assumption of the normality of the distributions of the indicators is accepted when using the Shapiro-Wilk criterion (W>0.8). Comparison of data obeying the law of normal distribution is the Welch T–test. The survival curve is based on the Kaplan-Meyer method. The Taron-Ware criterion was chosen to calculate the reliability of changes in survival. Results. Our study confirmed the geroprotective properties of fucoxanthin against mammals, showed the antioxidant properties of the drug and the absence of pronounced toxic effects. Conclusions. Fucoxanthin can be considered as a promising geroprotector for clinical use.

2 November 2026 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
APA. Yu. Popova
A. Yu. Popova
VGV. E. Gazhonova
V. E. Gazhonova
VKV. A. Kalyadin
V. A. Kalyadin
MMM. I. Magdalyanova
M. I. Magdalyanova
ADA. V. Dorofeev
A. V. Dorofeev
РАР. А. Аристов
Р. А. Аристов
Introduction . Breast cancer (BC) molecular subtypes differ not only in prognosis and response to systemic therapy, but also in morphological features that determine imaging appearance. A comprehensive assessment of digital mammography and ultrasound findings may reflect tumor biology and provide additional information about the probable molecular subtype at the stage of primary imaging. The purpose of the study is to identify multimodal visual phenotypes of luminal HER2‑negative, HER2‑positive, and triple-negative stage T1 BC based on the integrated assessment of digital mammography and ultrasound findings. Materials and methods . This multicenter retrospective cross-sectional study was based on archived medical records of 345 patients with morphologically verified invasive stage T1 BC. Digital mammography, breast ultrasound with color Doppler mapping and strain elastography, and morphological and immunohistochemical examinations had been performed as part of routine medical care before the data were included in the analysis. According to the immunohistochemical profile, the records were assigned to three groups: luminal HER2‑negative BC (n = 215), HER2‑ positive BC (n = 74), and triple-negative BC (n = 56). Results . Luminal HER2‑negative BC was characterized by a hyperdense mass with spiculated margins, posterior acoustic shadowing, predominantly peripheral vascularity, and high tissue stiffness. HER2‑positive BC showed a higher frequency of pleomorphic microcalcifications with linear or segmental distribution and frequent visualization of calcifications on ultrasound. Triple-negative BC was characterized by the absence of microcalcifications, posterior acoustic enhancement, mixed or intranodular vascularity, and a predominance of Tsukuba elasticity score 5. Conclusion . The main molecular subtypes of stage T1 BC demonstrate stable multimodal visual phenotypes. Integrated interpretation of mammographic and ultrasound features may serve as an additional tool for preoperative assessment of tumor biological characteristics.